Peregrine Pharmaceuticals, Inc. – Product Pipeline Review –

1. 2012 ||Product Pipeline|| Peregrine Pharmaceuticals, Inc. – Product Pipeline Review || Aarkstore.comhttp://www.aarkstore.com/reports/Peregrine-Pharmaceuticals-Inc-Product-Pipeline-Review-2012-236223.html You can also request for sample page of above mention reports on sample@aarkstore.com

2. Pages : 95PDF - $ 1500 | Site Licence - $ 3000 $ | Enterprise License - $ 4500 • 20% Off on above 1000$ Reports 25% off on purchase of 2 reports and 30% on purchase of 3 or more reports. • Discount till 31st Dec. 2012.

3. SummaryGlobal Market Direct’s pharmaceuticals report, “Peregrine Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Peregrine Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Peregrine Pharmaceuticals, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Peregrine Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

4. Scope- Peregrine Pharmaceuticals, Inc. - Brief Peregrine Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.- Review of current pipeline of Peregrine Pharmaceuticals, Inc. human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.Reasons to buy- Evaluate Peregrine Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Peregrine Pharmaceuticals, Inc. in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the Peregrine Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

5. Table Of Contents List of Tables 5 List of Figures 6 Peregrine Pharmaceuticals, Inc. Snapshot 7 Peregrine Pharmaceuticals, Inc. Overview 7 Key Information 7 Key Facts 7 Peregrine Pharmaceuticals, Inc. – Research and Development Overview 8 Key Therapeutic Areas 8 Peregrine Pharmaceuticals, Inc. – Pipeline Review 11 Pipeline Products by Stage of Development 11 Pipeline Products – Monotherapy 12 Pipeline Products – Combination Treatment Modalities 13 Peregrine Pharmaceuticals, Inc. – Pipeline Products Glance 14 Peregrine Pharmaceuticals, Inc. Clinical Stage Pipeline Products 14 Phase II Products/Combination Treatment Modalities 14 Phase I Products/Combination Treatment Modalities 15 Peregrine Pharmaceuticals, Inc. – Early Stage Pipeline Products 16 Pre-Clinical Products/Combination Treatment Modalities 16 Peregrine Pharmaceuticals, Inc. – Drug Profiles 17 131I-chTNT-1/B Mab 17 Product Description 17………………………………….

6. Related Reports:Product Pipeline Review – 2012 http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review – 2012&PubId=&pagenum=1 Actinium Pharmaceuticals, Inc. – Product Pipeline Review – 2012VakzineProjekt Management GmbH – Product Pipeline Review – 2012Torrent Pharmaceuticals Limited – Product Pipeline Review – 2012ViroMed Co., Ltd. – Product Pipeline Review – 2012Otsuka Holdings Co., Ltd. – Product Pipeline Review – 2012Suven Life Sciences Ltd. – Product Pipeline Review – 2012TrimelBioPharma SRL – Product Pipeline Review – 2012

7. For More details about above & other Reports plz contact :Lavanya Aarkstore.com Contact: Marketing team Mob.No.918149852585  Email: enquiry@aarkstore.com URL: http://www.aarkstore.comhttp://in.linkedin.com/in/aarkstorehttp://www.facebook.com/aarkstore